As diabetes care continues to be a major focus, innovative treatments are emerging . Retatrutide, Tirzepatide, and Semaglutide represent a noteworthy evolution in GLP-1 receptor agonist medications. While all https://wisesocialsmedia.com/story7697333/retatrutid-vs-that-medication-vs-semaglutide-a-direct-look